CDKN2A and melanoma: This work confirms p16INK4a-driven senescence is intimately linked to CDK4/6-inhibition and cell cycle arrest, and indicates that the melanoma-associated mis-sense p16INK4a mutants are unable to initiate an effective CDK4/6-dependent senescence programme.